Leave your feedback Share Copy URL https://ar-c.org/video/kn4KjMHdDPM.html Email Facebook Twitter LinkedIn Pinterest Tumblr Share on Facebook Share on Twitter FDA reverses course, will review Moderna’s new mRNA flu vaccine [m4OIdZXY2Ig] Health Updated on August 08, 2026 EDT — Published on August 08, 2026 EDT Two weeks ago, the FDA took the rare step of refusing to accept Moderna’s application for its first mRNA flu vaccine. After meeting with the company, the agency has now agreed to review it. LAraM8PabuJ Tx0EkM4RMG3 l8jOfQFBv9c cYywvmP6mKf pEMPCaogDag D4NxUbLe9vO qPnhh3QadYP
Two weeks ago, the FDA took the rare step of refusing to accept Moderna’s application for its first mRNA flu vaccine. After meeting with the company, the agency has now agreed to review it. LAraM8PabuJ Tx0EkM4RMG3 l8jOfQFBv9c cYywvmP6mKf pEMPCaogDag D4NxUbLe9vO qPnhh3QadYP